Pages that link to "Q35094801"
Jump to navigation
Jump to search
The following pages link to Bone density changes with once weekly risedronate in postmenopausal women (Q35094801):
Displaying 8 items.
- Advanced glycation end products play adverse proinflammatory activities in osteoporosis (Q27024641) (← links)
- Risedronate for prevention and treatment of osteoporosis in postmenopausal women (Q36082078) (← links)
- Update on osteoporosis therapy (Q36658960) (← links)
- DXA scanning in clinical practice. (Q37107665) (← links)
- Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate. (Q37323596) (← links)
- Transplantable delivery systems for in situ controlled release of bisphosphonate in orthopedic therapy. (Q37822757) (← links)
- The aminobisphosphonate risedronate preserves localized mineral and material properties of bone in the presence of glucocorticoids. (Q43466832) (← links)
- Risedronate reduces postoperative bone resorption after cementless total hip arthroplasty (Q80442873) (← links)